NCT04737044

Brief Summary

Study 1: To investigate the effects of antioxidant-rich sugar as alternative compared to granulated sugar on gene expression and other metabolic parameters in healthy subjects. The hypotheses is antioxidant-rich sugar have positive effects on reducing inflammatory cytokines, oxidative stress biomarkers and other metabolic parameters in intervention group compared to control group. Study 2: To evaluate the effectiveness of a nutrition education module in modifying sugar consumption and other CMR-related outcomes in individuals with cardiometabolic risk. The hypotheses is the nutrition education module significantly improves the sugar consumption and other CMR-related outcomes in the intervention groups compared to the control group

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 3, 2021

Completed
12 months until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

4 months

First QC Date

January 15, 2021

Last Update Submit

February 6, 2023

Conditions

Keywords

Antioxidant sugarGene ExpressionCardio metabolic risksEducation tool

Outcome Measures

Primary Outcomes (8)

  • Study 1: Gene expression of inflammation biomarkers (interleukin-6)

    Change from baseline in gene expression of interleukin-6 in micrograms at 8th weeks.

    8 weeks

  • Study 1: Gene expression of inflammation biomarkers (TNF-α)

    Change from baseline in gene expression of TNF-α in picograms per milliliter at 8th weeks.

    8 weeks

  • Study 1: Gene expression of inflammation biomarkers (CPR)

    Change from baseline in gene expression of CPR in milligram per liter at 8th weeks.

    8 weeks

  • Study 1: Gene expression of oxidative stress biomarkers (MDA)

    Change from baseline in gene expression of MDA in millimolar at 8th weeks.

    8 weeks

  • Study 1: Gene expression of oxidative stress biomarkers (SOD)

    Change from baseline in gene expression of SOD in Units per milliliter at 8th weeks.

    8 weeks

  • Study 1: Gene expression of oxidative stress biomarkers (CAT)

    Change from baseline in gene expression of CAT in nanomoles at 8th weeks.

    8 weeks

  • Study 2: Change from baseline in sugar consumption

    Dietary sugar intake will be determined using a 3-day food record and semi-quantitative FFQ of added sugar intake. Total sugar (grams per day) in foods will be calculated using formula \[(total sugar (grams) - natural sugar (grams)\]. The total added sugar intake will be divided into four centiles i.e., 25th percentile \[\<10.3g (2 tsps.)\], 50th percentile \[10.3-23.8g (2-5 tsps.)\], 75th percentile \[23.8-47.0g (5-9 tsps.)\] and 100th percentiles \[\>47g (9 tsps.)\].

    3 months

  • Study 2: Change from baseline in sugar consumption

    Dietary sugar intake will be determined using a 3-day food record and semi-quantitative FFQ of added sugar intake. Total sugar (grams per day) in foods will be calculated using formula \[(total sugar (grams) - natural sugar (grams)\]. The total added sugar intake will be divided into four centiles i.e., 25th percentile \[\<10.3g (2 tsps.)\], 50th percentile \[10.3-23.8g (2-5 tsps.)\], 75th percentile \[23.8-47.0g (5-9 tsps.)\] and 100th percentiles \[\>47g (9 tsps.)\].

    6 months

Secondary Outcomes (51)

  • Study 1: Inflammation biomarkers (interleukin-6)

    8 weeks

  • Study 1: Inflammation biomarkers (TNF-α)

    8 weeks

  • Study 1: Inflammation biomarkers (CPR)

    8 weeks

  • Study 1: Oxidative stress biomarkers (MDA)

    8 weeks

  • Study 1: Oxidative stress biomarkers (SOD)

    8 weeks

  • +46 more secondary outcomes

Study Arms (5)

Study 1: Normal sugar

NO INTERVENTION

Control group will be required to continue consuming normal sugar intake for 8 weeks.

Study 1:Minimally refined brown sugar (MRBS)

EXPERIMENTAL

Intervention group will be required to consume MRBS as added sugar based on their habitual diet for 8 weeks intervention.

Other: Study 1: MRBS

Study 2: Normal sugar intake

NO INTERVENTION

\- The control group will have no intervention and will continue with their normal daily intake for six months.

Study 2: White sugar

EXPERIMENTAL

* Intervention group I will be advised to reduce sugar intake to no more than 10% from total energy intake. * Intervention group I will be given white sugar for daily usage. * Participants in this group will be exposed to the nutrition education module (45 minutes per session, once a week) for six months, attend lecture classes and communicate with health educators through communication applications. * For the first three months, one-to-one diet counseling will be conducted. * Participants' intake of free sugar, as well as other nutrients (carbohydrate, protein, fats, fibre and others) will be closely monitored to ensure compliance to dietary recommendations.

Other: Study 2: White sugar & education module

Study 2: MRBS

EXPERIMENTAL

* Intervention group II will be advised to reduce sugar intake to no more than 10% from total energy intake. * Intervention group II will be given MRBS for daily usage. * Participants in this group will be exposed to the nutrition education module (45 minutes per session, once a week) for six months, attend lecture classes and communicate with health educators through communication applications. * For the first three months, one-to-one diet counseling will be conducted. * Participants' intake of free sugar, as well as other nutrients (carbohydrate, protein, fats, fibre and others) will be closely monitored to ensure compliance to dietary recommendations.

Other: Study 2: MRBS & education module

Interventions

MRBS as added sugar based on their habitual diet

Also known as: Food-based and gene expression
Study 1:Minimally refined brown sugar (MRBS)

White sugar for daily usage (\<10% daily energy intake)

Also known as: Food-based and nutrition education study
Study 2: White sugar

MRBS for daily usage (\<10% daily energy intake)

Also known as: Food-based and nutrition education study
Study 2: MRBS

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Willingness to adhere to study protocol
  • Healthy adults to be aged between 18 and 60 years in both genders
  • Being non-smoker
  • Body mass index (BMI) between 23 - 26.9 kg/m2 (overweight).

You may not qualify if:

  • Present of any kidney, liver and/or inflammatory disease (inflammatory bowel disease, Rheumatoid arthritis and etc.), thyroid disorder, diabetes (Type 1 \& Type 2), cardiovascular or metabolic disease
  • Individuals with impaired glucose tolerance or with fasting blood glucose level that more than 5.2 mmol/L
  • Pregnancy or lactation
  • Alcohol consumption, food allergy
  • Individuals who are on regular antioxidant, anti-inflammatory and /or anti-obesity drugs, receiving any glucose lowering and/or lipid lowering medications
  • Change in the diet and physical activity (significant weight changes during study period)
  • Subjects who habitually consumed beverages rich in sugar such as milo, Teh tarik more than 500 ml, (as tested with the FFQ)
  • Study 2:
  • Candidates will be screened for:
  • Cardiometabolic risk factors (waist circumference, blood pressure, fasting blood glucose, triglyceride and high-density lipoprotein cholesterol)
  • Pregnancy or breast feeding
  • Mental health status
  • Daily total sugar intake
  • Malaysian, aged ≥18-59 years old
  • Able to read, write and communicate well either in Malay or English
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universiti Putra Malaysia

Serdang, Selangor, 43400, Malaysia

Location

Related Publications (1)

  • Chiang WL, Mohd Yusof BN, Azlan A, Ismail IZ, Abu Zaid Z. Impacts of a nutrition education intervention in individuals with cardiometabolic risk: Protocol of a randomized controlled trial. Clin Nutr ESPEN. 2022 Jun;49:536-543. doi: 10.1016/j.clnesp.2022.03.037. Epub 2022 Mar 31.

MeSH Terms

Conditions

Metabolic Syndrome

Interventions

Gene Expression

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Genetic Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Study 1: The study will be using a two-arm single-blinded RCT with 40 subjects in each of the intervention and control groups. Study 2: The study will be using a three-arm RCT with 23 subjects in each groups (two interventions and one control groups).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor Dr Barakatun Nisak Mohd Yusof

Study Record Dates

First Submitted

January 15, 2021

First Posted

February 3, 2021

Study Start

February 1, 2022

Primary Completion

June 1, 2022

Study Completion

July 1, 2022

Last Updated

February 8, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations